SCHEMBL1721753

SCHEMBL1721753

CC(C)OC(=O)N1CCC(CCOc2ccc(Br)cn2)CC1

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 19/20 0.54
FAAH O00519 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL865849 0.89 GPR119 (0.52) GPR119FAAH
SCHEMBL1720752 0.84 GPR119 (0.62) GPR119FAAH
SCHEMBL609865 0.82 GPR119 (0.45) GPR119FAAH
SCHEMBL865755 0.82 GPR119 (0.58) GPR119
SCHEMBL456819 0.80 GPR119 (0.67) GPR119FAAH
SCHEMBL15632943 0.77 IDO1 (0.40)
SCHEMBL457426 0.76 GPR119 (0.62) GPR119FAAH
SCHEMBL3844800 0.76 HRH3 (0.44) GPR119
SCHEMBL13160668 0.76 GPR119 (0.52) GPR119FAAH
SCHEMBL387056 0.76 GPR119 (0.49) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406247-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS Prosidion Limited (GB) 2012-01-18 EP disclosed
EP-2406256-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS Prosidion Limited (GB) 2012-01-18 EP disclosed
WO-2010103333-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2010-09-16 WO disclosed
WO-2010103335-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2010-09-16 WO disclosed